153 related articles for article (PubMed ID: 15886987)
1. [Comparison of several viral vectors for gene therapy of corneal endothelial cells].
Beutelspacher SC; Serbecic N; Tan P; McClure MO
Ophthalmologe; 2005 Dec; 102(12):1168-74. PubMed ID: 15886987
[TBL] [Abstract][Full Text] [Related]
2. Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction.
Beutelspacher SC; Ardjomand N; Tan PH; Patton GS; Larkin DF; George AJ; McClure MO
Exp Eye Res; 2005 Jun; 80(6):787-94. PubMed ID: 15939034
[TBL] [Abstract][Full Text] [Related]
3. Comparison of gene transfer efficiencies and gene expression levels achieved with equine infectious anemia virus- and human immunodeficiency virus type 1-derived lentivirus vectors.
O'Rourke JP; Newbound GC; Kohn DB; Olsen JC; Bunnell BA
J Virol; 2002 Feb; 76(3):1510-5. PubMed ID: 11773424
[TBL] [Abstract][Full Text] [Related]
4. Gene transduction efficiency in cells of different species by HIV and EIAV vectors.
Ikeda Y; Collins MK; Radcliffe PA; Mitrophanous KA; Takeuchi Y
Gene Ther; 2002 Jul; 9(14):932-8. PubMed ID: 12085241
[TBL] [Abstract][Full Text] [Related]
5. Transient foamy virus vector production by adenovirus vectors.
Russell RA; Vassaux G; Martin-Duque P; McClure MO
Gene Ther; 2004 Feb; 11(3):310-6. PubMed ID: 14737091
[TBL] [Abstract][Full Text] [Related]
6. Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells.
Siapati EK; Bigger BW; Miskin J; Chipchase D; Parsley KL; Mitrophanous K; Themis M; Thrasher AJ; Bonnet D
Mol Ther; 2005 Sep; 12(3):537-46. PubMed ID: 16099415
[TBL] [Abstract][Full Text] [Related]
7. Foamy virus-adenovirus hybrid vectors for gene therapy of the arthritides.
Weber C; Armbruster N; Scheller C; Kreppel F; Kochanek S; Rethwilm A; Steinert AF
J Gene Med; 2013; 15(3-4):155-67. PubMed ID: 23554302
[TBL] [Abstract][Full Text] [Related]
8. Suppression of neovascularization of donor corneas by transduction with equine infectious anemia virus-based lentiviral vectors expressing endostatin and angiostatin.
Parker M; Bellec J; McFarland T; Scripps V; Appukuttan B; Hartzell M; Yeager A; Hady T; Mitrophanous KA; Stout T; Ellis S
Hum Gene Ther; 2014 May; 25(5):408-18. PubMed ID: 24460027
[TBL] [Abstract][Full Text] [Related]
9. Pseudotyping and culture conditions affect efficiency and cytotoxicity of retroviral gene transfer to human corneal endothelial cells.
Valtink M; Stanke N; Knels L; Engelmann K; Funk RH; Lindemann D
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6807-13. PubMed ID: 21757582
[TBL] [Abstract][Full Text] [Related]
10. Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectors.
Balaggan KS; Binley K; Esapa M; Iqball S; Askham Z; Kan O; Tschernutter M; Bainbridge JW; Naylor S; Ali RR
J Gene Med; 2006 Mar; 8(3):275-85. PubMed ID: 16299834
[TBL] [Abstract][Full Text] [Related]
11. Analysis of gene transfer and expression in skeletal muscle using enhanced EIAV lentivirus vectors.
O'Rourke JP; Hiraragi H; Urban K; Patel M; Olsen JC; Bunnell BA
Mol Ther; 2003 May; 7(5 Pt 1):632-9. PubMed ID: 12718906
[TBL] [Abstract][Full Text] [Related]
12. Efficient Transduction of Corneal Stroma by Adeno-Associated Viral Serotype Vectors for Implications in Gene Therapy of Corneal Diseases.
Lu Y; Ai J; Gessler D; Su Q; Tran K; Zheng Q; Xu X; Gao G
Hum Gene Ther; 2016 Aug; 27(8):598-608. PubMed ID: 27001051
[TBL] [Abstract][Full Text] [Related]
13. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
[TBL] [Abstract][Full Text] [Related]
14. New methods to titrate EIAV-based lentiviral vectors.
Martin-Rendon E; White LJ; Olsen A; Mitrophanous KA; Mazarakis ND
Mol Ther; 2002 May; 5(5 Pt 1):566-70. PubMed ID: 11991747
[TBL] [Abstract][Full Text] [Related]
15. In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies.
Lamikanra A; Myers KA; Ferris N; Mitrophanous KA; Carroll MW
Gene Ther; 2005 Jun; 12(12):988-98. PubMed ID: 15772687
[TBL] [Abstract][Full Text] [Related]
16. Optimization of equine infectious anemia derived vectors for hematopoietic cell lineage gene transfer.
O'Rourke JP; Olsen JC; Bunnell BA
Gene Ther; 2005 Jan; 12(1):22-9. PubMed ID: 15550928
[TBL] [Abstract][Full Text] [Related]
17. Cryopreservation and lentiviral-mediated genetic modification of human primary cultured corneal endothelial cells.
Suh LH; Zhang C; Chuck RS; Stark WJ; Naylor S; Binley K; Chakravarti S; Jun AS
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3056-61. PubMed ID: 17591873
[TBL] [Abstract][Full Text] [Related]
18. Both HIV- and EIAV-based lentiviral vectors mediate gene delivery to pancreatic cancer cells and human pancreatic primary patient xenografts.
Saraga G; Mafficini A; Ghaneh P; Sorio C; Costello E
Cancer Gene Ther; 2007 Sep; 14(9):781-90. PubMed ID: 17571071
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Equine Infectious Anemia Virus Integration in the Horse Genome.
Liu Q; Wang XF; Ma J; He XJ; Wang XJ; Zhou JH
Viruses; 2015 Jun; 7(6):3241-60. PubMed ID: 26102582
[TBL] [Abstract][Full Text] [Related]
20. Equine infectious anemia viral vector-mediated codelivery of endostatin and angiostatin driven by retinal pigmented epithelium-specific VMD2 promoter inhibits choroidal neovascularization.
Kachi S; Binley K; Yokoi K; Umeda N; Akiyama H; Muramatu D; Iqball S; Kan O; Naylor S; Campochiaro PA
Hum Gene Ther; 2009 Jan; 20(1):31-9. PubMed ID: 20377369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
